Recent publications · Crossref
5 total works indexed
- Olaparib for Metastatic Breast Cancer in Patients with a Germline
<i>BRCA</i>
Mutation
· 2017 · cited 2,836x
- 2023 ESC Guidelines for the management of cardiomyopathies
· 2023 · cited 2,250x
- Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trial
· 2012 · cited 2,004x
- Adjuvant Olaparib for Patients with
<i>BRCA1</i>
- or
<i>BRCA2</i>
-Mutated Breast Cancer
· 2021 · cited 1,472x